Asia Pacific Pharmaceutical Cro Market Size & Outlook
Asia Pacific pharmaceutical cro market, 2018-2030 (US$M)
Related Markets
Asia Pacific pharmaceutical cro market highlights
- The Asia Pacific pharmaceutical cro market generated a revenue of USD 19,124.0 million in 2024.
- The market is expected to grow at a CAGR of 9% from 2025 to 2030.
- In terms of segment, clinical was the largest revenue generating type in 2024.
- Pre-Clinical is the most lucrative type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2025 to 2030.
Asia Pacific data book summary
| Market revenue in 2024 | USD 19,124.0 million |
| Market revenue in 2030 | USD 32,105.5 million |
| Growth rate | 9% (CAGR from 2024 to 2030) |
| Largest segment | Clinical |
| Fastest growing segment | Pre-Clinical |
| Historical data covered | 2018 - 2023 |
| Base year for estimation | 2024 |
| Forecast period covered | 2025 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Discovery, Pre-Clinical, Clinical |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 46.4% of the global pharmaceutical cro market in 2024.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 32,105.5 million by 2030.
Clinical was the largest segment with a revenue share of 75.61% in 2024. Horizon Databook has segmented the Asia Pacific pharmaceutical cro market based on drug discovery, pre-clinical, clinical covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific held the largest market share of 46.40% in 2024, attributed to various factors, such as the stringent standards for patient safety in conducting clinical trials, cheap labor, and access to a large patient pool, which are propelling market growth.
In addition, the rising adoption of global R&D standards to meet international requirements and low operating costs are key factors responsible for the growing demand for outsourcing services across the Asia Pacific region. Likewise, the development of outsourcing hubs, the expansion of market players, and the availability of skilled practitioners further contribute to the market's growth.
For instance, in March 2024, TFS Health Science announced the expansion in the Asia Pacific region, establishing an operational base in Australia. The expansion will allow the company to provide comprehensive clinical research services & support partners with a broader reach to patients, fostering innovative solutions & global collaboration.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Pharmaceutical CRO Market Scope
Pharmaceutical CRO Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific pharmaceutical cro market size, by country, 2018-2030 (US$M)
Asia Pacific Pharmaceutical CRO Market Outlook Share, 2024 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
